Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
The Allstate Corporation furnished its third‑quarter 2025 financial results via a Form 8‑K. Under Item 2.02, the company made available a press release and an investor supplement as exhibits, stating these materials are furnished and not filed pursuant to Instruction B.2.
The submission includes Exhibit 99.1 (press release dated November 5, 2025) and Exhibit 99.2 (Third Quarter 2025 Investor Supplement). The filing also lists Allstate’s registered securities and trading symbols on the New York Stock Exchange.
Allstate Corporation (ALL) reported an insider equity transaction. On 11/03/2025, officer Zulfikar Jeevanjee converted 5,110 previously awarded restricted stock units into an equal number of common shares, without payment of consideration, under The Allstate Corporation 2019 Equity Incentive Plan.
On the same date, a separate transaction coded “F” shows the disposition of 2,251 common shares at $191.25 per share. Following these transactions, Jeevanjee directly beneficially owns 10,431 Allstate common shares.
A selling stockholder filed a Form 144 to sell up to 33,614 shares of common stock, with an aggregate market value of $6,428,677.5. The notice lists Goldman Sachs & Co. LLC as broker and an approximate sale date of 11/03/2025 on the NYSE.
The seller is identified as the Thomas J. Wilson Revocable Trust dtd 03/13/15. The filing also reports prior sales over the past three months: 16,807 shares on 10/06/2025 for $3,532,582.66 and 16,807 shares on 10/20/2025 for $3,260,884.06.
Context from the notice shows 263,505,334 shares outstanding and indicates portions of the position were originally acquired as compensation via performance awards on 02/22/2018 and 02/08/2019.
Allstate Corp filed a Form 13F reporting its institutional holdings as of the filing period. The report lists 633 portfolio entries with a total market value of $4,381,321,904 and names 2 other included managers.
The filing is signed by Alexandra Band, Senior Vice President & CFO Investment Finance, and identifies the reporting managers as Allstate Investment Management Co and Allstate Investments LLC. This is a routine quarterly holdings disclosure by an institutional manager.
Allstate (ALL) CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025. Tranches executed at weighted-average prices of $193.6903, $194.3583, $195.5023, and $196.5001.
After the transactions, he directly owns 195,233.491 Allstate shares. He also reports indirect beneficial holdings, including 111,442 shares by the 2023-B GRAT and 273,954 shares by the 2020 GRAT Remainder Trust.
The Allstate Corporation furnished a Form 8-K under Regulation FD to make available its September 2025 monthly release. The update, posted on allstateinvestors.com and attached as Exhibit 99, announces estimated catastrophe losses and policies in force. The company states the exhibit is furnished and not filed pursuant to Instruction B.2.
This is an informational disclosure intended to provide investors with the latest monthly catastrophe loss estimates and policy counts; specific figures were not included in the excerpt.
Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation (ALL), reported open-market sales executed under a Rule 10b5-1 trading plan adopted on 06/27/2025. On 10/06/2025 he sold a total of 16,807 shares in three reported transactions with weighted average prices of $209.6272, $210.4799, and $211.1514; reported sale price ranges were $209.070–$211.280.
After these transactions the reporting person shows 212,040.491 shares held directly and several indirect holdings through trusts and plans totaling 785,718 shares (listed by vehicle). The Form 4 states the sales were effected pursuant to the trading plan and discloses dividend reinvestment activity adding 33.037 shares during April–October 2025.
Mario Rizzo, listed as Chief Operating Officer-AIC of The Allstate Corporation (ALL), reported changes in his beneficial ownership on 10/03/2025 via a Form 4. The filing shows 199 shares acquired upon conversion of a 2022 performance stock award and 89 shares withheld for tax obligations, leaving 68,814 shares reported as directly beneficially owned after the transactions. The report also discloses 1,662 shares held indirectly through a 401(k) plan. In derivative holdings, 224 employee stock options were reported as acquired with an exercise price of $210.82 and an expiration in 2035, and 57 restricted stock units (RSUs) were granted that convert in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The Form is signed by an attorney-in-fact on 10/07/2025.
Allstate Corporation (ALL) reporting person Jesse E. Merten completed equity transactions tied to long‑term awards and an option exercise in early October 2025. On 10/05/2025 538 shares were acquired on conversion of a 2022 performance stock award and 239 shares were withheld to cover tax obligations related to that conversion. Separately, an employee stock option with a $210.82 exercise price was exercised on 10/03/2025 producing 213 underlying shares, and 54 restricted stock units were granted on 10/03/2025 that vest in three equal increments through 10/03/2028. Following these actions, the reporting person beneficially owned 21,526 shares directly and 7,706 shares indirectly via a 401(k) plan.
Insider award of 7,115 restricted stock units at no cost, vesting in three equal annual installments. An executive officer, Zulfikar Jeevanjee (EVP & CTO - AIC), was granted 7,115 Restricted Stock Units (RSUs) on 10/03/2025 under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU converts to one share of Allstate common stock without payment on the conversion dates. The RSUs vest in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The reported grant shows 0 purchase price per unit and results in 7,115 shares beneficially owned following the award.